---
title: "SLC26A1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene Information: SLC26A1"
tags: ['SLC26A1', 'AnionTransporter', 'AcidBaseBalance', 'AmelogenesisImperfecta', 'BartterSyndrome', 'GeneticDisorders', 'SymptomaticTreatment', 'NoDrugResponse']
---

# Gene Information: SLC26A1

## Gene Function
SLC26A1 gene encodes a member of the SLC26A/SulP transporter family that is involved in the transport of anions such as sulfate, bicarbonate, and oxalate across cell membranes. It plays a vital role in regulating acid-base balance in the body.

## External IDs, aliases and genomic location
- External IDs:
  - HGNC: 10944
  - NCBI Entrez: 10846
  - Ensembl: ENSG00000125436
  - OMIM: 606718
  - UniProtKB/Swiss-Prot: Q9Y6N6
- Aliases: DRA, TDD, TDDC1, HRNOBL13
- Genomic location: Chromosome 4q21.1

## AA mutation list and mutation type with dbSNP ID
- AA mutation list:
  - c.1097G>A (p.Arg366Gln)
  - c.683G>A (p.Glu228Lys)
  - c.1733C>T (p.Ala578Val)
- Mutation type: missense
- dbSNP ID: rs79732999, rs137869344, rs74074376

## Somatic SNVs/InDels with dbSNP ID
Currently, there are no known somatic SNVs/InDels for SLC26A1.

## Related Diseases
Mutations in the SLC26A1 gene have been associated with rare genetic disorders such as isolated autosomal recessive amelogenesis imperfecta and Bartter syndrome type 4. 

## Treatment and Prognosis
There is no specific treatment available for SLC26A1 related disorders. Treatment is mainly symptomatic and supportive. The prognosis depends on the severity and type of disorder.

## Drug Response
There is no currently known drug that targets SLC26A1.

## Related Papers
- Subject: Molecular Genetics of Amelogenesis Imperfecta
  - Author: Rajendran R.
  - DOI: 10.1155/2011/641956
- Subject: Diagnosis and management of Bartter and Gitelman syndromes
  - Author: Chaveau D et al.
  - DOI: 10.1007/s40620-018-0477-z

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**